US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 19.560
  • -0.390-1.95%
Close Sep 27 16:00 ET
  • 19.560
  • 0.0000.00%
Post 19:59 ET
2.32BMarket Cap34.93P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
108.54%64.14M
164.50%31.93M
23.74%143.6M
38.85%55.65M
9.27%45.13M
17.42%30.75M
42.37%12.07M
92.22%116.05M
109.00%40.08M
90.27%41.3M
Net income from continuing operations
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
120.23%22.75M
Operating gains losses
----
----
----
----
----
----
----
--762K
--0
--129K
Depreciation and amortization
10.09%9.44M
42.88%9.43M
2,553.83%32.88M
1,386.67%9.14M
1,449.37%8.57M
23,062.16%8.57M
19,311.76%6.6M
545.31%1.24M
1,763.64%615K
1,683.87%553K
Deferred tax
50.20%-1.61M
-14.94%-1.75M
-460.91%-17.82M
-31.28%883K
-1,592.83%-13.94M
-496.45%-3.24M
-179.91%-1.52M
-47.01%4.94M
-53.19%1.29M
-59.41%934K
Other non cash items
212.31%203K
13.92%221K
1,794.06%83.23M
3,814.29%2.47M
1,816.67%80.5M
-10.96%65K
234.48%194K
1,431.01%4.39M
-21.25%63K
3,900.00%4.2M
Change In working capital
155.06%8.65M
66.31%-8.65M
-371.86%-37.32M
-28.58%7.65M
-133.80%-3.61M
-1,687.66%-15.7M
-196.40%-25.67M
173.38%13.73M
93.55%10.72M
43.79%10.68M
-Change in receivables
135.35%3.32M
69.61%-6.98M
-1,027.62%-43.08M
-395.92%-5.47M
-2,201.20%-5.25M
-1,073.47%-9.39M
-483.85%-22.96M
-504.43%-3.82M
-18,466.67%-1.1M
175.08%250K
-Change in inventory
558.39%1.94M
-846.79%-4.31M
-544.98%-4.74M
-2,121.10%-6.61M
139.00%1.72M
-1,739.13%-423K
1,241.86%577K
133.08%1.07M
135.54%327K
388.44%718K
-Change in prepaid assets
-476.76%-9.81M
-533.51%-1.21M
-617.72%-5.79M
203.26%1.43M
-1,056.55%-5.33M
-392.60%-1.7M
66.07%-191K
-120.29%-807K
-1,894.81%-1.38M
-82.66%557K
-Change in payables and accrued expense
423.90%13.28M
231.07%3.94M
-5.56%16.62M
41.96%18.39M
-42.18%5.34M
-797.37%-4.1M
27.27%-3.01M
336.46%17.6M
100.74%12.95M
109.81%9.24M
-Change in other current liabilities
-9.52%-92K
-8.54%-89K
-10.10%-338K
-10.26%-86K
-8.86%-86K
-9.09%-84K
-12.33%-82K
-135.53%-307K
0.00%-78K
---79K
Cash from discontinued investing activities
Operating cash flow
108.54%64.14M
164.50%31.93M
23.74%143.6M
38.85%55.65M
9.27%45.13M
17.42%30.75M
42.37%12.07M
92.22%116.05M
109.00%40.08M
90.27%41.3M
Investing cash flow
Cash flow from continuing investing activities
-10K
99.88%-199K
-3,287.12%-293.5M
-38.32M
-70,215.91%-92.82M
0
-162.37M
183.56%9.21M
0
-94.12%-132K
Net PPE purchase and sale
---10K
-168.92%-199K
-696.55%-231K
---93K
---64K
--0
---74K
97.16%-29K
--0
--0
Net intangibles purchase and sale
----
----
---81.51M
---2.23M
----
----
----
--0
--0
----
Net investment purchase and sale
----
----
-169.99%-13.47M
--0
----
----
----
292.38%19.24M
--0
--9.87M
Net other investing changes
----
----
-1,882.93%-198.29M
---36M
--0
--0
---162.29M
---10M
--0
----
Cash from discontinued investing activities
Investing cash flow
---10K
99.88%-199K
-3,287.12%-293.5M
---38.32M
-70,215.91%-92.82M
--0
---162.37M
183.56%9.21M
--0
-94.12%-132K
Financing cash flow
Cash flow from continuing financing activities
640.65%1.16M
94,563.76%141.05M
-740.91%-10.86M
-129.52%-665K
-354.19%-10.13M
92.85%-214K
109.61%149K
120.80%1.69M
189.19%2.25M
289.90%3.98M
Net common stock issuance
--0
--140.7M
--0
--0
--0
--0
--0
42.87%-6.91M
--0
--0
Proceeds from stock option exercised by employees
229.17%2.03M
19.84%1.52M
-70.82%2.79M
-78.35%693K
-94.68%212K
-55.42%617K
27.00%1.27M
133.45%9.57M
367.30%3.2M
34.82%3.98M
Net other financing activities
-5.17%-874K
-5.00%-1.18M
-1,310.02%-13.65M
-43.25%-1.36M
---10.34M
---831K
---1.12M
-532.68%-968K
-597.06%-948K
--0
Cash from discontinued financing activities
Financing cash flow
640.65%1.16M
94,563.76%141.05M
-740.91%-10.86M
-129.52%-665K
-354.19%-10.13M
92.85%-214K
109.61%149K
120.80%1.69M
189.19%2.25M
289.90%3.98M
Net cash flow
Beginning cash position
109.39%310.41M
-53.87%137.64M
74.05%298.4M
-52.76%120.97M
-15.23%178.79M
-16.89%148.25M
74.05%298.4M
31.64%171.45M
65.38%256.07M
55.89%210.91M
Current changes in cash
113.76%65.28M
215.07%172.78M
-226.63%-160.76M
-60.63%16.67M
-228.04%-57.82M
-6.15%30.54M
-2,267.58%-150.15M
208.07%126.95M
154.86%42.33M
131.07%45.15M
End cash Position
110.13%375.69M
109.39%310.41M
-53.87%137.64M
-53.87%137.64M
-52.76%120.97M
-15.23%178.79M
-16.89%148.25M
74.05%298.4M
74.05%298.4M
65.38%256.07M
Free cash flow
108.51%64.13M
164.47%31.73M
-46.68%61.86M
33.07%53.33M
-182.86%-34.22M
17.55%30.75M
41.50%12M
95.48%116.02M
109.44%40.08M
90.86%41.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 108.54%64.14M164.50%31.93M23.74%143.6M38.85%55.65M9.27%45.13M17.42%30.75M42.37%12.07M92.22%116.05M109.00%40.08M90.27%41.3M
Net income from continuing operations 8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M120.23%22.75M
Operating gains losses ------------------------------762K--0--129K
Depreciation and amortization 10.09%9.44M42.88%9.43M2,553.83%32.88M1,386.67%9.14M1,449.37%8.57M23,062.16%8.57M19,311.76%6.6M545.31%1.24M1,763.64%615K1,683.87%553K
Deferred tax 50.20%-1.61M-14.94%-1.75M-460.91%-17.82M-31.28%883K-1,592.83%-13.94M-496.45%-3.24M-179.91%-1.52M-47.01%4.94M-53.19%1.29M-59.41%934K
Other non cash items 212.31%203K13.92%221K1,794.06%83.23M3,814.29%2.47M1,816.67%80.5M-10.96%65K234.48%194K1,431.01%4.39M-21.25%63K3,900.00%4.2M
Change In working capital 155.06%8.65M66.31%-8.65M-371.86%-37.32M-28.58%7.65M-133.80%-3.61M-1,687.66%-15.7M-196.40%-25.67M173.38%13.73M93.55%10.72M43.79%10.68M
-Change in receivables 135.35%3.32M69.61%-6.98M-1,027.62%-43.08M-395.92%-5.47M-2,201.20%-5.25M-1,073.47%-9.39M-483.85%-22.96M-504.43%-3.82M-18,466.67%-1.1M175.08%250K
-Change in inventory 558.39%1.94M-846.79%-4.31M-544.98%-4.74M-2,121.10%-6.61M139.00%1.72M-1,739.13%-423K1,241.86%577K133.08%1.07M135.54%327K388.44%718K
-Change in prepaid assets -476.76%-9.81M-533.51%-1.21M-617.72%-5.79M203.26%1.43M-1,056.55%-5.33M-392.60%-1.7M66.07%-191K-120.29%-807K-1,894.81%-1.38M-82.66%557K
-Change in payables and accrued expense 423.90%13.28M231.07%3.94M-5.56%16.62M41.96%18.39M-42.18%5.34M-797.37%-4.1M27.27%-3.01M336.46%17.6M100.74%12.95M109.81%9.24M
-Change in other current liabilities -9.52%-92K-8.54%-89K-10.10%-338K-10.26%-86K-8.86%-86K-9.09%-84K-12.33%-82K-135.53%-307K0.00%-78K---79K
Cash from discontinued investing activities
Operating cash flow 108.54%64.14M164.50%31.93M23.74%143.6M38.85%55.65M9.27%45.13M17.42%30.75M42.37%12.07M92.22%116.05M109.00%40.08M90.27%41.3M
Investing cash flow
Cash flow from continuing investing activities -10K99.88%-199K-3,287.12%-293.5M-38.32M-70,215.91%-92.82M0-162.37M183.56%9.21M0-94.12%-132K
Net PPE purchase and sale ---10K-168.92%-199K-696.55%-231K---93K---64K--0---74K97.16%-29K--0--0
Net intangibles purchase and sale -----------81.51M---2.23M--------------0--0----
Net investment purchase and sale ---------169.99%-13.47M--0------------292.38%19.24M--0--9.87M
Net other investing changes ---------1,882.93%-198.29M---36M--0--0---162.29M---10M--0----
Cash from discontinued investing activities
Investing cash flow ---10K99.88%-199K-3,287.12%-293.5M---38.32M-70,215.91%-92.82M--0---162.37M183.56%9.21M--0-94.12%-132K
Financing cash flow
Cash flow from continuing financing activities 640.65%1.16M94,563.76%141.05M-740.91%-10.86M-129.52%-665K-354.19%-10.13M92.85%-214K109.61%149K120.80%1.69M189.19%2.25M289.90%3.98M
Net common stock issuance --0--140.7M--0--0--0--0--042.87%-6.91M--0--0
Proceeds from stock option exercised by employees 229.17%2.03M19.84%1.52M-70.82%2.79M-78.35%693K-94.68%212K-55.42%617K27.00%1.27M133.45%9.57M367.30%3.2M34.82%3.98M
Net other financing activities -5.17%-874K-5.00%-1.18M-1,310.02%-13.65M-43.25%-1.36M---10.34M---831K---1.12M-532.68%-968K-597.06%-948K--0
Cash from discontinued financing activities
Financing cash flow 640.65%1.16M94,563.76%141.05M-740.91%-10.86M-129.52%-665K-354.19%-10.13M92.85%-214K109.61%149K120.80%1.69M189.19%2.25M289.90%3.98M
Net cash flow
Beginning cash position 109.39%310.41M-53.87%137.64M74.05%298.4M-52.76%120.97M-15.23%178.79M-16.89%148.25M74.05%298.4M31.64%171.45M65.38%256.07M55.89%210.91M
Current changes in cash 113.76%65.28M215.07%172.78M-226.63%-160.76M-60.63%16.67M-228.04%-57.82M-6.15%30.54M-2,267.58%-150.15M208.07%126.95M154.86%42.33M131.07%45.15M
End cash Position 110.13%375.69M109.39%310.41M-53.87%137.64M-53.87%137.64M-52.76%120.97M-15.23%178.79M-16.89%148.25M74.05%298.4M74.05%298.4M65.38%256.07M
Free cash flow 108.51%64.13M164.47%31.73M-46.68%61.86M33.07%53.33M-182.86%-34.22M17.55%30.75M41.50%12M95.48%116.02M109.44%40.08M90.86%41.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data